This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Palm, Zanett: Week's Big Volume Movers

Stocks in this article: ZANE CIGX PALM

Less than 12 hours later, Zanett said in a regulatory filing it will issue a convertible note in principal amount of $7.13 million in exchange for a $5.32 million promissory note and $3 million line of credit. The new convertible note bears a rate of 7.95% and matures in March 2015 with an initial conversion price of $2.08 per share. Compare that with Zanett's closing price Tuesday of $3.27.

Needless to say, Zanett investors weren't happy that news of dilution came so quickly after the very bullish PR Tuesday morning. This should have came as little surprise to those who have followed Zanett in the past, though.

Zanett made headlines on March 3 when it acknowledged it would receive a second delisting notice from the Nasdaq after it failed to meet the exchange's minimum bid price requirement before a March 15 deadline. At the time, shares hovered around 30 cents a piece.

One day later, Zanett announced the closing of over $12 million in new business during the first two months of 2010, and shares rallied to more than $3 in subsequent sessions. The rapid ascent in share price left investors to wonder why Zanett had not included the contract news with the Nasdaq delisting warning, much like the way investors now are wondering why Zanett wouldn't include the financing news at the same time it announced the $17.1 million in new business.

The lesson here is simple: If Zanett issues a press release, investors may be better off waiting until the company spits out all the words before they take a position in the stock.


Star Scientific (CIGX) shares were all over the charts this week, falling as low as $2.42 and trading as high as $3.69. Trading volume was heaviest on Wednesday after Star Scientific announced a collaboration with Roskamp Institute on Beta-amyloid discovery to treat Alzheimer's disease. According to the company, preliminary tests showed that when a compound developed by Star Scientific is applied to cells, B-amyloid is reduced. The stock immediately shot higher but quickly retreated after traders began to parse the news release.

2 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 18,053.71 +23.50 0.13%
S&P 500 2,088.77 +6.89 0.33%
NASDAQ 4,806.8590 +33.3870 0.70%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs